Pular para o conteúdo
Merck

Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma.

Genes & development (2017-08-23)
Lucía Simón-Carrasco, Osvaldo Graña, Marina Salmón, Harrys K C Jacob, Alejandro Gutierrez, Gerardo Jiménez, Matthias Drosten, Mariano Barbacid
RESUMO

CIC (also known as Capicua) is a transcriptional repressor negatively regulated by RAS/MAPK signaling. Whereas the functions of Cic have been well characterized in Drosophila, little is known about its role in mammals. CIC is inactivated in a variety of human tumors and has been implicated recently in the promotion of lung metastases. Here, we describe a mouse model in which we inactivated Cic by selectively disabling its DNA-binding activity, a mutation that causes derepression of its target genes. Germline Cic inactivation causes perinatal lethality due to lung differentiation defects. However, its systemic inactivation in adult mice induces T-cell acute lymphoblastic lymphoma (T-ALL), a tumor type known to carry CIC mutations, albeit with low incidence. Cic inactivation in mice induces T-ALL by a mechanism involving derepression of its well-known target, Etv4 Importantly, human T-ALL also relies on ETV4 expression for maintaining its oncogenic phenotype. Moreover, Cic inactivation renders T-ALL insensitive to MEK inhibitors in both mouse and human cell lines. Finally, we show that Ras-induced mouse T-ALL as well as human T-ALL carrying mutations in the RAS/MAPK pathway display a genetic signature indicative of Cic inactivation. These observations illustrate that CIC inactivation plays a key role in this human malignancy.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Anticorpo anti-fosfohistona H2A.X (Ser139), clone JBW301, clone JBW301, Upstate®, from mouse
Sigma-Aldrich
Anti-GAPDH antibody, Mouse monoclonal, clone GAPDH-71.1, purified from hybridoma cell culture